Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Diagnostic Pathology|October 15, 2020
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinomaHong Kyu Lee, Mi Jung Kwon, Yong Joon Ra, et al.
Human Pathology|March 22, 2016
Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic valueMi Jung Kwon, Jeong Won Kim, Jae Pil Jung, et al.
Pathology, Research and Practice|October 22, 2019
BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysisKyueng-Whan Min, Ji-Young Choe, Mi Jung Kwon, et al.
Cancer Research and Treatment|January 16, 2018
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract CancerChanghoon Yoo, Boram Han, Hyeong Su Kim, et al.
Human Pathology|March 10, 2019
Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targetsHa Young Park, Mi Jung Kwon, Ho Suk Kang, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 2016
Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancerKyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, et al.
World Journal of Surgery|August 24, 2016
Invasion Depth Measured in Millimeters is a Predictor of Survival in Patients with Distal Bile Duct Cancer: Decision Tree ApproachKyueng-Whan Min, Dong-Hoon Kim, Byoung Kwan Son, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 14, 2017
Expression Pattern of Smad4/GATA3 as a Predictor of Survival in Invasive Ductal Carcinoma of the BreastKyueng-Whan Min, Dong-Hoon Kim, Sung-Im Do, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 27, 2018
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11Hyeong Su Kim, Min-Hee Ryu, Dae Young Zang, et al.
EMBO Reports|May 18, 2022
PWWP2B promotes DNA end resection and homologous recombinationMin Kyung Ju, Joo Rak Lee, Yeonsong Choi, et al.
Pageof 6